Mgtx stock
What makes MeiraGTx Holdings plc (MgTX) a strong momentum stock to buy? What makes MeiraGTx Holdings PLC (MGTX) a very dynamic stock? Buy now? MeiraGTx Holdings Plc develops new methods of gene therapy. He specializes in hereditary retinal disorders, neurodegenerative diseases and severe xerostomia.
Who sold MgTX stock in the last quarter?
MGTX shares were sold in the past quarter by several institutional investors, including JPMorgan Chase & Co., Longitude Cayman Ltd., Price T Rowe Associates Inc., MD, California Government Employee Pension System, Bank of America Corp DE, UBS Asset Management Americas C., Vanguard Group Inc. and Virtus ETF Advisers LLC.
What do analysts see for MeiraGTx's share price in the next year?
3 Wall Street analysts have published year-over-year target prices for MeiraGTxs. Their forecasts average between $ and $, they predict that the MeiraGTxs share price will reach $ next year. This indicates a possible increase in the current price of the stock.
What does MeiraGTx do?
About MeiraGTx MeiraGTx (Nasdaq: MGTX) is a clinical-stage vertically integrated gene therapy company with six clinical development programs and a broad portfolio of research and preclinical programs.
What makes meiragtx holdings plc (mgtx) a strong momentum stock to buy back
Zacks promoted MeiraGTx Holdings PLC (MGTX) to #1 (strong buy), reflecting growing optimism about the company's earnings outlook. This could push stocks up in the short term. Short quote from MGTX.
What makes meiragtx holdings plc (mgtx) a strong momentum stock to buy 2020
Posted by Zacks Equity Research Posted on June 26, 2020 MeiraGTx Holdings PLC (MGTX) has been upgraded to 1st Zacks (Strong Buy), reflecting growing optimism about the company's earnings outlook. This could push stocks up in the short term.
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
What makes meiragtx holdings plc (mgtx) a strong momentum stock to buy 2019
MeiraGTx Holdings PLC (MGTX) Goes Active Buy: Reasons To Upgrade From Zacks Equity Research Posted On June 26, 2020 Operating Income Forecast. This could push stocks up in the short term.
![:brown_circle:]( ":brown_circle:")
Who buys MgTX stock?
MGTX shares were purchased in the quarter by several institutional investors, including BlackRock Inc., Salem Investment Counselors Inc.
![:brown_circle:]( ":brown_circle:")
What is MeiraGTx Holdings plc's (MgTX) return on equity?
MeiraGTx Holdings plc (NASDAQ: MGTX) announced the results on Wednesday, August 11. The company reported earnings per share of $($) for the quarter, above the consensus of $($) per share. MeiraGTx had a negative return on equity compared to the prior year and a negative net margin of.
Is MeiraGTx a buy or sell?
Wall Street analysts have given MeiraGTx a buy recommendation, but there may be better buying opportunities in the stock market. Some of MarketBeats' previous successful trading ideas resulted in 515% weekly gains. MarketBeat had just unveiled five new stock ideas, but MeiraGTx was not one of them.
Who sold mgtx stock in the last quarter of all time
In the last quarter, MGTX shares were sold by these institutional investors: BlackRock Inc. Ensign Peak Advisors Inc.
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
What is the upside for MeiraGTx's stock?
Their forecasts average between $ and $, they predict that the MeiraGTxs share price will reach $ next year. This indicates a possible increase in the current value of the share. Check out analyst target prices on MeiraGTx or check out the top-rated analyst stocks on Wall Street.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
How much does MeiraGTx make a year?
MeiraGTx has a market cap of millions of dollars and generates millions in revenue annually. The company has $57,990 each year in net income (earnings) or (dollars) based on earnings per share. How many employees does MeiraGTx have?
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
What is MeiraGTx's mailing address?
MeiraGTx's mailing address is 450 East 29th Street 14thFloor, NEW YORK NY, 10016. You can contact the company by calling (646) 8607985 or emailing Investors@.
What does meiragtx do for the body
Because methamphetamine constricts blood vessels, it blocks constant blood flow to all parts of the body. Heavy use can weaken and destroy these blood vessels, making tissues vulnerable to damage and hindering the body's ability to repair itself. Acne occurs, wounds take longer to heal and the skin loses its radiance and elasticity.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
Why choose MeiraGTx?
Try again later. MeiraGTx develops and markets innovative gene therapy products to change the lives of patients with inherited and acquired diseases.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What does MeiraGTx do in Shannon?
MeiraGTx, a clinical-stage gene therapy company, has confirmed it will build multi-million dollar facilities in County Clare's Shannon Free Zone. The new facility is currently under construction and is being developed by Shannon Commercial Properties, a subsidiary of the Shannon Group.
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
What is MeiraGTx doing to treat radiation-induced xerostomia?
MeiraGTx is developing AAVAQP1 to treat radiation-induced xerostomia (RIX) by increasing water flow in radiation-damaged salivary glands. Your gene therapy product candidate works by introducing a waterway into the remaining epithelial cells of these damaged glands.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What is MeiraGTx doing to treat achromatopsia?
MeiraGTx is currently conducting Phase 1/2 clinical trials with AAVCNGB3 in adults and children with color blindness (ACHM) due to mutations in the CNGB3 gene.
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
What does meiragtx do for you
MeiraGTx is a clinical-stage gene therapy company specializing in the development of potentially therapeutic treatments for patients with serious diseases. Six programs are currently in clinical development, including four indications in the eye, salivary gland disease and the Parkinson's program.
Who is MeiraGTx CEO Richard Giroux?
Richard Giroud has been COO since March 2015 and COO and CFO since April 2019. Mr. Giroud joined MeiraGTx after working for Sarissa Capital Management LP, a hedge fund for health activists, where he was a partner from March 2014 to March 2015.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
Who are the medical leaders at MeiraGTx?
dr. Naylor holds a degree in microbiology and virology from the University of Warwick, a degree in immunology from King's College London and the Imperial Cancer Research Foundation Laboratory of Ovarian Cancer and Cytokine Biology. dr. Robert Zeldin has been medical director of MeiraGTx since August 2020.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
Who is MeiraGTx's general counsel and Secretary?
Robert Wallin joined MeiraGTx in August 2019 and is General Counsel and Secretary. Prior to joining MeiraGTx, Mr. Wallin was Director, Deputy General Counsel at Investment Technology Group, Inc. (NYSE: ITM), a global fintech company.
![:brown_circle:]( ":brown_circle:")
Does MeiraGTx Holdings plc (MgTX) stock deliver strong earnings and revenue surprises?
MeiraGTx Holdings PLC (MGTX) has released stunning profit and loss data for the quarter ended March 2021. Do the numbers give any clues to the future of stocks?
